52 participants
BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-12-09
- Start Date:
- 2013-05-31
- Completion:
- 2022-02-28
Conditions
- Metastatic or Locally-advanced Unresectable Breast Cancer
Interventions
- DRUG